Company intelligence / Profile preview

Diatos S.A.

Ownership: Private
Development stage: Commercial

Overview

Diatos S.A. was a Paris-based biopharmaceutical company focused on developing improved chemotherapeutic agents with enhanced tumor targeting or biodistribution using proprietary prodrug and drug delivery platforms such as Vectocell®. Its lead product, DaunoXome®, was marketed for Kaposi's sarcoma and under review for AML; additional candidates included DTS‑201 and DTS‑108 targeting solid tumors. The company advanced at least eight compounds through clinical development before its core technology assets were acquired by others.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculesProdrugsLiposomal formulations (e.g., DaunoXome®)
Industry: Biotech

Drug pipeline

1 asset

dts-201

Unknown

Partnerships

Drais Pharmaceuticals – global agreement to develop/commercialize DTS–108 ($46.9M non–royalty value)Gilead Sciences – exclusive licensing agreement for DaunoXome worldwide rightsMedarex – European commercialization rights granted to Diatos for DTS–201.

Beyond the preview

Go deeper on Diatos S.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diatos S.A..

Explore the full profile